Zenotech Laboratories Ltd

NSE: ZENOTECH · BSE: 532039 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹41.85
Market cap: ₹255.4 Cr
Revenue (annual): ₹43.61 Cr
Net profit (annual): ₹-1.07 Cr
P/E (TTM): -101.5×Sector 47.4×
Promoter holding: 68.84%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 2 Annual General Meeting 2 Price Movement Clarification 1 Debt & Borrowing 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 Apr 2026 15:02 IST BSE

Debt & Borrowing

Zenotech Laboratories Debt & Borrowing

Zenotech Laboratories Limited confirmed it is not classified as a Large Corporate (LC) per SEBI's debt-raising framework. The company reported zero outstanding borrowings as of March 31, 2026. Consequently, mandatory initial disclosure requirements for large corporates do not apply.

Read the filing ↗